Global Therapeutic Recombinant Protein Supply, Demand and Key Producers, 2023-2029

Description

The global Therapeutic Recombinant Protein market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Therapeutic recombinant proteins are proteins that are produced by recombinant DNA technology and are used as drugs to treat various medical conditions. Recombinant DNA technology involves the use of genetically engineered microorganisms or cells to produce large quantities of a specific protein that has therapeutic potential. Therapeutic recombinant proteins are used to treat a wide range of medical conditions, including cancer, autoimmune diseases, genetic disorders, and infectious diseases. These proteins are designed to mimic the natural proteins in the body that regulate various biological processes. They are often administered by injection, and their effectiveness depends on the specific protein and the medical condition being treated.

This report studies the global Therapeutic Recombinant Protein demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Therapeutic Recombinant Protein, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Therapeutic Recombinant Protein that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Therapeutic Recombinant Protein total market, 2018-2029, (USD Million)
Global Therapeutic Recombinant Protein total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Therapeutic Recombinant Protein total market, key domestic companies and share, (USD Million)
Global Therapeutic Recombinant Protein revenue by player and market share 2018-2023, (USD Million)
Global Therapeutic Recombinant Protein total market by Type, CAGR, 2018-2029, (USD Million)
Global Therapeutic Recombinant Protein total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Therapeutic Recombinant Protein market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abcam, HALIX, Avantor, Miltenyi Biotec, Thermo Fisher Scientific, Bio-Techne Corporation, Merck, ACROBiosystems and Abnova, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Therapeutic Recombinant Protein market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Therapeutic Recombinant Protein Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Therapeutic Recombinant Protein Market, Segmentation by Type
    Hormones
    Blood Clotting Factors
    Cytokines
    Enzymes
    Fusion Proteins
    Others

Global Therapeutic Recombinant Protein Market, Segmentation by Application
    Pharmaceutical Company
    Research Institute
    Others

Companies Profiled:
    Abcam
    HALIX
    Avantor
    Miltenyi Biotec
    Thermo Fisher Scientific
    Bio-Techne Corporation
    Merck
    ACROBiosystems
    Abnova
    Eurogentec (Kaneka Corporation)
    Cytiva (Danaher )
    Reprocell
    GenScript
    BPS Bioscience
    Sino Biological

Key Questions Answered
1. How big is the global Therapeutic Recombinant Protein market?
2. What is the demand of the global Therapeutic Recombinant Protein market?
3. What is the year over year growth of the global Therapeutic Recombinant Protein market?
4. What is the total value of the global Therapeutic Recombinant Protein market?
5. Who are the major players in the global Therapeutic Recombinant Protein market?

Table of Contents

1 Supply Summary
    1.1 Therapeutic Recombinant Protein Introduction
    1.2 World Therapeutic Recombinant Protein Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Therapeutic Recombinant Protein Total Market by Region (by Headquarter Location)
        1.3.1 World Therapeutic Recombinant Protein Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Therapeutic Recombinant Protein Market Size (2018-2029)
        1.3.3 China Therapeutic Recombinant Protein Market Size (2018-2029)
        1.3.4 Europe Therapeutic Recombinant Protein Market Size (2018-2029)
        1.3.5 Japan Therapeutic Recombinant Protein Market Size (2018-2029)
        1.3.6 South Korea Therapeutic Recombinant Protein Market Size (2018-2029)
        1.3.7 ASEAN Therapeutic Recombinant Protein Market Size (2018-2029)
        1.3.8 India Therapeutic Recombinant Protein Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Therapeutic Recombinant Protein Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Therapeutic Recombinant Protein Major Market Trends

2 Demand Summary
    2.1 World Therapeutic Recombinant Protein Consumption Value (2018-2029)
    2.2 World Therapeutic Recombinant Protein Consumption Value by Region
        2.2.1 World Therapeutic Recombinant Protein Consumption Value by Region (2018-2023)
        2.2.2 World Therapeutic Recombinant Protein Consumption Value Forecast by Region (2024-2029)
    2.3 United States Therapeutic Recombinant Protein Consumption Value (2018-2029)
    2.4 China Therapeutic Recombinant Protein Consumption Value (2018-2029)
    2.5 Europe Therapeutic Recombinant Protein Consumption Value (2018-2029)
    2.6 Japan Therapeutic Recombinant Protein Consumption Value (2018-2029)
    2.7 South Korea Therapeutic Recombinant Protein Consumption Value (2018-2029)
    2.8 ASEAN Therapeutic Recombinant Protein Consumption Value (2018-2029)
    2.9 India Therapeutic Recombinant Protein Consumption Value (2018-2029)

3 World Therapeutic Recombinant Protein Companies Competitive Analysis
    3.1 World Therapeutic Recombinant Protein Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Therapeutic Recombinant Protein Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Therapeutic Recombinant Protein in 2022
        3.2.3 Global Concentration Ratios (CR8) for Therapeutic Recombinant Protein in 2022
    3.3 Therapeutic Recombinant Protein Company Evaluation Quadrant
    3.4 Therapeutic Recombinant Protein Market: Overall Company Footprint Analysis
        3.4.1 Therapeutic Recombinant Protein Market: Region Footprint
        3.4.2 Therapeutic Recombinant Protein Market: Company Product Type Footprint
        3.4.3 Therapeutic Recombinant Protein Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Therapeutic Recombinant Protein Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Therapeutic Recombinant Protein Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Therapeutic Recombinant Protein Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Therapeutic Recombinant Protein Consumption Value Comparison
        4.2.1 United States VS China: Therapeutic Recombinant Protein Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Therapeutic Recombinant Protein Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Therapeutic Recombinant Protein Companies and Market Share, 2018-2023
        4.3.1 United States Based Therapeutic Recombinant Protein Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Therapeutic Recombinant Protein Revenue, (2018-2023)
    4.4 China Based Companies Therapeutic Recombinant Protein Revenue and Market Share, 2018-2023
        4.4.1 China Based Therapeutic Recombinant Protein Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Therapeutic Recombinant Protein Revenue, (2018-2023)
    4.5 Rest of World Based Therapeutic Recombinant Protein Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Therapeutic Recombinant Protein Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Therapeutic Recombinant Protein Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Therapeutic Recombinant Protein Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Hormones
        5.2.2 Blood Clotting Factors
        5.2.3 Cytokines
        5.2.4 Enzymes
        5.2.5 Fusion Proteins
        5.2.6 Others
    5.3 Market Segment by Type
        5.3.1 World Therapeutic Recombinant Protein Market Size by Type (2018-2023)
        5.3.2 World Therapeutic Recombinant Protein Market Size by Type (2024-2029)
        5.3.3 World Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Therapeutic Recombinant Protein Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical Company
        6.2.2 Research Institute
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Therapeutic Recombinant Protein Market Size by Application (2018-2023)
        6.3.2 World Therapeutic Recombinant Protein Market Size by Application (2024-2029)
        6.3.3 World Therapeutic Recombinant Protein Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Abcam
        7.1.1 Abcam Details
        7.1.2 Abcam Major Business
        7.1.3 Abcam Therapeutic Recombinant Protein Product and Services
        7.1.4 Abcam Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Abcam Recent Developments/Updates
        7.1.6 Abcam Competitive Strengths & Weaknesses
    7.2 HALIX
        7.2.1 HALIX Details
        7.2.2 HALIX Major Business
        7.2.3 HALIX Therapeutic Recombinant Protein Product and Services
        7.2.4 HALIX Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 HALIX Recent Developments/Updates
        7.2.6 HALIX Competitive Strengths & Weaknesses
    7.3 Avantor
        7.3.1 Avantor Details
        7.3.2 Avantor Major Business
        7.3.3 Avantor Therapeutic Recombinant Protein Product and Services
        7.3.4 Avantor Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Avantor Recent Developments/Updates
        7.3.6 Avantor Competitive Strengths & Weaknesses
    7.4 Miltenyi Biotec
        7.4.1 Miltenyi Biotec Details
        7.4.2 Miltenyi Biotec Major Business
        7.4.3 Miltenyi Biotec Therapeutic Recombinant Protein Product and Services
        7.4.4 Miltenyi Biotec Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Miltenyi Biotec Recent Developments/Updates
        7.4.6 Miltenyi Biotec Competitive Strengths & Weaknesses
    7.5 Thermo Fisher Scientific
        7.5.1 Thermo Fisher Scientific Details
        7.5.2 Thermo Fisher Scientific Major Business
        7.5.3 Thermo Fisher Scientific Therapeutic Recombinant Protein Product and Services
        7.5.4 Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Thermo Fisher Scientific Recent Developments/Updates
        7.5.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
    7.6 Bio-Techne Corporation
        7.6.1 Bio-Techne Corporation Details
        7.6.2 Bio-Techne Corporation Major Business
        7.6.3 Bio-Techne Corporation Therapeutic Recombinant Protein Product and Services
        7.6.4 Bio-Techne Corporation Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Bio-Techne Corporation Recent Developments/Updates
        7.6.6 Bio-Techne Corporation Competitive Strengths & Weaknesses
    7.7 Merck
        7.7.1 Merck Details
        7.7.2 Merck Major Business
        7.7.3 Merck Therapeutic Recombinant Protein Product and Services
        7.7.4 Merck Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Merck Recent Developments/Updates
        7.7.6 Merck Competitive Strengths & Weaknesses
    7.8 ACROBiosystems
        7.8.1 ACROBiosystems Details
        7.8.2 ACROBiosystems Major Business
        7.8.3 ACROBiosystems Therapeutic Recombinant Protein Product and Services
        7.8.4 ACROBiosystems Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 ACROBiosystems Recent Developments/Updates
        7.8.6 ACROBiosystems Competitive Strengths & Weaknesses
    7.9 Abnova
        7.9.1 Abnova Details
        7.9.2 Abnova Major Business
        7.9.3 Abnova Therapeutic Recombinant Protein Product and Services
        7.9.4 Abnova Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Abnova Recent Developments/Updates
        7.9.6 Abnova Competitive Strengths & Weaknesses
    7.10 Eurogentec (Kaneka Corporation)
        7.10.1 Eurogentec (Kaneka Corporation) Details
        7.10.2 Eurogentec (Kaneka Corporation) Major Business
        7.10.3 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product and Services
        7.10.4 Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Eurogentec (Kaneka Corporation) Recent Developments/Updates
        7.10.6 Eurogentec (Kaneka Corporation) Competitive Strengths & Weaknesses
    7.11 Cytiva (Danaher )
        7.11.1 Cytiva (Danaher ) Details
        7.11.2 Cytiva (Danaher ) Major Business
        7.11.3 Cytiva (Danaher ) Therapeutic Recombinant Protein Product and Services
        7.11.4 Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Cytiva (Danaher ) Recent Developments/Updates
        7.11.6 Cytiva (Danaher ) Competitive Strengths & Weaknesses
    7.12 Reprocell
        7.12.1 Reprocell Details
        7.12.2 Reprocell Major Business
        7.12.3 Reprocell Therapeutic Recombinant Protein Product and Services
        7.12.4 Reprocell Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Reprocell Recent Developments/Updates
        7.12.6 Reprocell Competitive Strengths & Weaknesses
    7.13 GenScript
        7.13.1 GenScript Details
        7.13.2 GenScript Major Business
        7.13.3 GenScript Therapeutic Recombinant Protein Product and Services
        7.13.4 GenScript Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.13.5 GenScript Recent Developments/Updates
        7.13.6 GenScript Competitive Strengths & Weaknesses
    7.14 BPS Bioscience
        7.14.1 BPS Bioscience Details
        7.14.2 BPS Bioscience Major Business
        7.14.3 BPS Bioscience Therapeutic Recombinant Protein Product and Services
        7.14.4 BPS Bioscience Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.14.5 BPS Bioscience Recent Developments/Updates
        7.14.6 BPS Bioscience Competitive Strengths & Weaknesses
    7.15 Sino Biological
        7.15.1 Sino Biological Details
        7.15.2 Sino Biological Major Business
        7.15.3 Sino Biological Therapeutic Recombinant Protein Product and Services
        7.15.4 Sino Biological Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023)
        7.15.5 Sino Biological Recent Developments/Updates
        7.15.6 Sino Biological Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Therapeutic Recombinant Protein Industry Chain
    8.2 Therapeutic Recombinant Protein Upstream Analysis
    8.3 Therapeutic Recombinant Protein Midstream Analysis
    8.4 Therapeutic Recombinant Protein Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Therapeutic Recombinant Protein Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Therapeutic Recombinant Protein Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Therapeutic Recombinant Protein Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Therapeutic Recombinant Protein Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Therapeutic Recombinant Protein Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Therapeutic Recombinant Protein Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Therapeutic Recombinant Protein Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Therapeutic Recombinant Protein Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Therapeutic Recombinant Protein Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Therapeutic Recombinant Protein Players in 2022
    Table 12. World Therapeutic Recombinant Protein Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Therapeutic Recombinant Protein Company Evaluation Quadrant
    Table 14. Head Office of Key Therapeutic Recombinant Protein Player
    Table 15. Therapeutic Recombinant Protein Market: Company Product Type Footprint
    Table 16. Therapeutic Recombinant Protein Market: Company Product Application Footprint
    Table 17. Therapeutic Recombinant Protein Mergers & Acquisitions Activity
    Table 18. United States VS China Therapeutic Recombinant Protein Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Therapeutic Recombinant Protein Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Therapeutic Recombinant Protein Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Therapeutic Recombinant Protein Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Therapeutic Recombinant Protein Revenue Market Share (2018-2023)
    Table 23. China Based Therapeutic Recombinant Protein Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Therapeutic Recombinant Protein Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Therapeutic Recombinant Protein Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Therapeutic Recombinant Protein Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Therapeutic Recombinant Protein Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Therapeutic Recombinant Protein Revenue Market Share (2018-2023)
    Table 29. World Therapeutic Recombinant Protein Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Therapeutic Recombinant Protein Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Therapeutic Recombinant Protein Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Therapeutic Recombinant Protein Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Therapeutic Recombinant Protein Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Therapeutic Recombinant Protein Market Size by Application (2024-2029) & (USD Million)
    Table 35. Abcam Basic Information, Area Served and Competitors
    Table 36. Abcam Major Business
    Table 37. Abcam Therapeutic Recombinant Protein Product and Services
    Table 38. Abcam Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Abcam Recent Developments/Updates
    Table 40. Abcam Competitive Strengths & Weaknesses
    Table 41. HALIX Basic Information, Area Served and Competitors
    Table 42. HALIX Major Business
    Table 43. HALIX Therapeutic Recombinant Protein Product and Services
    Table 44. HALIX Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. HALIX Recent Developments/Updates
    Table 46. HALIX Competitive Strengths & Weaknesses
    Table 47. Avantor Basic Information, Area Served and Competitors
    Table 48. Avantor Major Business
    Table 49. Avantor Therapeutic Recombinant Protein Product and Services
    Table 50. Avantor Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Avantor Recent Developments/Updates
    Table 52. Avantor Competitive Strengths & Weaknesses
    Table 53. Miltenyi Biotec Basic Information, Area Served and Competitors
    Table 54. Miltenyi Biotec Major Business
    Table 55. Miltenyi Biotec Therapeutic Recombinant Protein Product and Services
    Table 56. Miltenyi Biotec Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Miltenyi Biotec Recent Developments/Updates
    Table 58. Miltenyi Biotec Competitive Strengths & Weaknesses
    Table 59. Thermo Fisher Scientific Basic Information, Area Served and Competitors
    Table 60. Thermo Fisher Scientific Major Business
    Table 61. Thermo Fisher Scientific Therapeutic Recombinant Protein Product and Services
    Table 62. Thermo Fisher Scientific Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Thermo Fisher Scientific Recent Developments/Updates
    Table 64. Thermo Fisher Scientific Competitive Strengths & Weaknesses
    Table 65. Bio-Techne Corporation Basic Information, Area Served and Competitors
    Table 66. Bio-Techne Corporation Major Business
    Table 67. Bio-Techne Corporation Therapeutic Recombinant Protein Product and Services
    Table 68. Bio-Techne Corporation Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Bio-Techne Corporation Recent Developments/Updates
    Table 70. Bio-Techne Corporation Competitive Strengths & Weaknesses
    Table 71. Merck Basic Information, Area Served and Competitors
    Table 72. Merck Major Business
    Table 73. Merck Therapeutic Recombinant Protein Product and Services
    Table 74. Merck Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Merck Recent Developments/Updates
    Table 76. Merck Competitive Strengths & Weaknesses
    Table 77. ACROBiosystems Basic Information, Area Served and Competitors
    Table 78. ACROBiosystems Major Business
    Table 79. ACROBiosystems Therapeutic Recombinant Protein Product and Services
    Table 80. ACROBiosystems Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. ACROBiosystems Recent Developments/Updates
    Table 82. ACROBiosystems Competitive Strengths & Weaknesses
    Table 83. Abnova Basic Information, Area Served and Competitors
    Table 84. Abnova Major Business
    Table 85. Abnova Therapeutic Recombinant Protein Product and Services
    Table 86. Abnova Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Abnova Recent Developments/Updates
    Table 88. Abnova Competitive Strengths & Weaknesses
    Table 89. Eurogentec (Kaneka Corporation) Basic Information, Area Served and Competitors
    Table 90. Eurogentec (Kaneka Corporation) Major Business
    Table 91. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Product and Services
    Table 92. Eurogentec (Kaneka Corporation) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Eurogentec (Kaneka Corporation) Recent Developments/Updates
    Table 94. Eurogentec (Kaneka Corporation) Competitive Strengths & Weaknesses
    Table 95. Cytiva (Danaher ) Basic Information, Area Served and Competitors
    Table 96. Cytiva (Danaher ) Major Business
    Table 97. Cytiva (Danaher ) Therapeutic Recombinant Protein Product and Services
    Table 98. Cytiva (Danaher ) Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Cytiva (Danaher ) Recent Developments/Updates
    Table 100. Cytiva (Danaher ) Competitive Strengths & Weaknesses
    Table 101. Reprocell Basic Information, Area Served and Competitors
    Table 102. Reprocell Major Business
    Table 103. Reprocell Therapeutic Recombinant Protein Product and Services
    Table 104. Reprocell Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 105. Reprocell Recent Developments/Updates
    Table 106. Reprocell Competitive Strengths & Weaknesses
    Table 107. GenScript Basic Information, Area Served and Competitors
    Table 108. GenScript Major Business
    Table 109. GenScript Therapeutic Recombinant Protein Product and Services
    Table 110. GenScript Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 111. GenScript Recent Developments/Updates
    Table 112. GenScript Competitive Strengths & Weaknesses
    Table 113. BPS Bioscience Basic Information, Area Served and Competitors
    Table 114. BPS Bioscience Major Business
    Table 115. BPS Bioscience Therapeutic Recombinant Protein Product and Services
    Table 116. BPS Bioscience Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 117. BPS Bioscience Recent Developments/Updates
    Table 118. Sino Biological Basic Information, Area Served and Competitors
    Table 119. Sino Biological Major Business
    Table 120. Sino Biological Therapeutic Recombinant Protein Product and Services
    Table 121. Sino Biological Therapeutic Recombinant Protein Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 122. Global Key Players of Therapeutic Recombinant Protein Upstream (Raw Materials)
    Table 123. Therapeutic Recombinant Protein Typical Customers
List of Figure
    Figure 1. Therapeutic Recombinant Protein Picture
    Figure 2. World Therapeutic Recombinant Protein Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Therapeutic Recombinant Protein Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Therapeutic Recombinant Protein Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Therapeutic Recombinant Protein Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Therapeutic Recombinant Protein Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Therapeutic Recombinant Protein Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Therapeutic Recombinant Protein Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Therapeutic Recombinant Protein Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Therapeutic Recombinant Protein Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Therapeutic Recombinant Protein Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Therapeutic Recombinant Protein Revenue (2018-2029) & (USD Million)
    Figure 13. Therapeutic Recombinant Protein Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Therapeutic Recombinant Protein Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Therapeutic Recombinant Protein Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Therapeutic Recombinant Protein by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Therapeutic Recombinant Protein Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Therapeutic Recombinant Protein Markets in 2022
    Figure 27. United States VS China: Therapeutic Recombinant Protein Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Therapeutic Recombinant Protein Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Therapeutic Recombinant Protein Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Therapeutic Recombinant Protein Market Size Market Share by Type in 2022
    Figure 31. Hormones
    Figure 32. Blood Clotting Factors
    Figure 33. Cytokines
    Figure 34. Enzymes
    Figure 35. Fusion Proteins
    Figure 36. Others
    Figure 37. World Therapeutic Recombinant Protein Market Size Market Share by Type (2018-2029)
    Figure 38. World Therapeutic Recombinant Protein Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 39. World Therapeutic Recombinant Protein Market Size Market Share by Application in 2022
    Figure 40. Pharmaceutical Company
    Figure 41. Research Institute
    Figure 42. Others
    Figure 43. Therapeutic Recombinant Protein Industrial Chain
    Figure 44. Methodology
    Figure 45. Research Process and Data Source

Companies Mentioned

Abcam
HALIX
Avantor
Miltenyi Biotec
Thermo Fisher Scientific
Bio-Techne Corporation
Merck
ACROBiosystems
Abnova
Eurogentec (Kaneka Corporation)
Cytiva (Danaher )
Reprocell
GenScript
BPS Bioscience
Sino Biological